Pharmaceutical care for patients with acne

Czech version

Authors: Tereza Toušková; Kateřina Malá-Ládová
Authors‘ workplace: Katedra sociální a klinické farmacie, Farmaceutická fakulta UK v Hradci Králové
Published in: Čes. slov. Farm., 2024; 73, 148-155
Category: Current Pharmacotherapy
doi: https://doi.org/10.36290/csf.2024.023

Overview

Acne is a multifactorial inflammatory skin disease affecting mostly adolescents, but it can persist into adulthood. The aim of treatment is to improve the patient’s dermatological condition and improve the overall quality of life. Pharmacists play a very important role in the care of acne patients and this article reviews opportunities for pharmaceutical care of such patients. Pharmacists can identify patients with different forms of acne, engage in acne prevention including lifestyle modifications, and contribute to optimizing the choice and use of appropriate pharmacotherapy accompanied by non-pharmacological approaches according to the specific patient characteristics. The mainstay of acne treatment is topical pharmacotherapy, where over-the-counter products containing benzoyl peroxide or azelaic acid may be recommended for mild to moderate forms of acne. Retinoids or their combination with antibiotics are prescribed for moderate and severe forms of acne. When topical treatment is ineffective or resistant, systemic treatment including for example oral antibiotics or isotretinoin is considered. Pharmacists thus engage themselves in maximizing the effect and minimizing the risks of these drugs and, last but not least, educating patients on how to properly care for their skin using so called dermocosmetics, which is defined in this article.

Keywords:

Acne – Pharmaceutical Care – cosmetic products – dermocosmetics – topical treatment – system treatment – pharmacy.

Sources

1. Eichenfield DZ, Sprague J, Eichenfield LF. Management of acne vulgaris: a review. Jama. 2021;326(20):2055-2067.

2. Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology. 2024;90(5):1006-e1.

3. Obstová I. Etiopatogeneze a terapie acne vulgaris. Dermatol Pro Praxi. [Internet]. 2015;9(3):111-115.

4. Gollnick H, Zouboulis CC. Acne vulgaris: Overview of management. In: UpToDate. 2024. Available from https://www.uptodate.com/contents/acne-vulgaris-overview-of-management.

5. Shen YC, Chiu WK, Kang YN, et al. Microneedling monotherapy for acne scar: systematic review and meta-analysis of randomized controlled trials. Aesthetic Plastic Surgery. 2022;46(4):1913-1922.

6. Dalgard F, Gieler U, Holm J, et al. Self-esteem and body satisfaction among late adolescents with acne: results from a population survey. Journal of the American Academy of Dermatology. 2008;59(5):746-751.

7. Whittlesea C, Hodson K. (Eds.). Clinical Pharmacy and Therapeutics E-Book: Clinical Pharmacy and Therapeutics E-Book. Elsevier Health Sciences. 2018.

8. França K. Topical probiotics in dermatological therapy and skincare: a concise review. Dermatology and therapy. 2021;11(1):71-77.

9. Pavelková M. Mastná pleť a akné – co doporučit v lékárně? Dermatol Praxi. 2022;18(3):170-174.

10. Podgorska A, Puścion-Jakubik A, Markiewicz-Żukowska R, et al. Acne vulgaris and intake of selected dietary nutrients – a summary of information. In Healthcare. 2021;9(6):668.

11. Kent DM, Steyerberg E, Van Klaveren D. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. Bmj. 2018: 363.

12. Mitchell BL, Saklatvala JR, Dand N, et al. Genome-wide association meta-analysis identifies 29 new acne susceptibility loci. Nature communications. 2022;13(1);702.

13. Fagron Genomics. AcneTest – DNA analýza pro léčbu akné na míru pacienta. Available from https://www.fagron-genomics.cz/ancetest-dna-analyza-pro-lecbu-akne-na-miru-pacienta.

14. Vantuchová MY. Lokální léčba akné. Dermatol Pro Praxi. 2014;8(4):140-143.

15. Státní ústav pro kontrolu léčiv. Databáze léků. Available from https://www.sukl.cz/modules/medication/search.php.

16. Dallo M, Patel K, Hebert AA. Topical antibiotic treatment in dermatology. Antibiotics. 2023;12(2):188.

17. Státní ústav pro kontrolu léčiv. Skinoren krém: Souhrn údajů o přípravku (SPC). Available from https://www.sukl.cz/modules/medication/detail.php?code=0022032.

18. Nevoralová Z. Nežádoucí účinky léčby akné a jejich řešení. Dermatol Pro Praxi. 2021;15(1):19-27.

19. Státní ústav pro kontrolu léčiv. Akneroxid: Souhrn údajů o přípravku (SPC). Available from https://www.sukl.cz/modules/medication/download.php?file=SPC175003.pdf & type=spc & as=akneroxid-spc.

20. Macháčková MK. Lokální léčba akné vulgaris. Dermatol Pro Praxi. 2018;12(2):78-80.

21. Chien AL, Qi J, Rainer B, Sachs, et al. Treatment of acne in pregnancy. The Journal of the American Board of Family Medicine. 2016;29(2):254-262.

22. Nevoralová MZ. Udržovací léčba akné. Dermatol Pro Praxi. 2016;10(1):10-15.

23. Leyden JJ, Del Rosso JQ. Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. The Journal of clinical and aesthetic dermatology 2011;4(2): 40.

24. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. Journal of the American Academy of Dermatology. 2009;60(5):S1-S50.

25. Státní ústav pro kontrolu léčiv. Deoxymykoin: Souhrn údajů o přípravku (SPC). Available from https://www.sukl.cz/modules/medication/detail.php?code=0090986 & tab=prices

26. Greenberger NJ. Absorption of tetracyclines: interference by iron. Annals of Internal Medicine. 1971;74(5):792-793.

27. Státní ústav pro kontrolu léčiv. Azitrox, Sumamed: Souhrn údajů o přípravku (SPC). Available from https://www.sukl.cz/modules/medication/detail.php?code=0090986 & tab=prices

28. Hrouzková MA. Současné přístupy k léčbě papulopustulózní akné. Dermatologie pro praxi. 2016;10(3):112-116.

29. Mavranezouli I, Daly CH, Welton NJ, et al. A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris. Br J Dermatol. 2022;187(5):639-649.

30. Státní ústav pro kontrolu léčiv. Dalacin C: Souhrn údajů o přípravku (SPC). Dostupné z: https://www.sukl.cz/modules/medication/detail.php?code=0090986 & tab=prices

31. National Institute for Health and Care Excellence (NICE). Management of acne vulgaris: summary of NICE guidance. BMJ. 2021;374:n1800.

32. Státní ústav pro kontrolu léčiv. Aknenormin, Curakné: Souhrn údajů o přípravku (SPC). Available from https://www.sukl.cz/modules/medication/detail.php?code=0090986 & tab=prices.

33. Rulcová J, Nevoralová Z, Benáková N. Obličejové dermatózy. Mladá fronta. 2016.

34. Allen RH Combined estrogen-progestin oral contraceptives: patient selection, counseling, and use. UpToDate, Waltham, MA. 2022. Available from https://www.uptodate.com/contents/combined-estrogen-progestin-oral-contraceptives-patient-selection-counseling-and-use.

35. DermNet. Anti-androgen therapy: Hormonal treatment for acne and hirsutism. 2023. Available from https://dermnetnz.org/topics/anti-androgen-therapy.

36. Zákon č. 258/2000 Sb., o ochraně veřejného zdraví a o změně některých souvisejících zákonů. Available from https://www.zakonyprolidi.cz/cs/2000-258.

37. Nařízení Evropského parlamentu a Rady (ES) č. 1223/2009 ze dne 30. listopadu 2009 o kosmetických přípravcích. Available from https://eur-lex.europa.eu/legal-content/CS/TXT/?uri=CELEX%3A32009R1223.

38. Nařízení Komise (EU) č. 655/2013 ze dne 10. července 2013, kterým se stanoví společná kritéria pro zdůvodnění tvrzení používaných ve vztahu ke kosmetickým výrobkům. Available from https://eur-lex.europa.eu/legal-content/CS/TXT/?uri=CELEX%3A32013R0655

39. Tan J, Bhate K, Hoeger PH, et al. The role and benefits of dermocosmetics in acne management in Japan. Dermatol Ther (Heidelb). 2023;13(7):1423-1433.

40. Araviiskaia E, Dreno B. The role of topical dermocosmetics in acne vulgaris. J Eur Acad Dermatol Venereol. 2016;30(6):926-935.

41. Saint-Leger D. Cosmeceuticals. Of men, science and laws. Int J Cosmet Sci. 2012;34(5):396-401.

42. Schäfer N, Sobczyk M, Burczyk D, et al. Possibilities of using vegetable oils in acne skin care. Aesth Cosmetol Med. 2022;11(2):49-54.

43. Kovács A, Péter-Héderi D, Perei K, et al. Effects of formulation excipients on skin barrier function in creams used in pediatric care. Pharmaceutics. 2020;12(729):1-15.

44. Nevoralová MZ. Úloha dermokosmetiky v léčbě akné. Dermatol Pro Praxi. 2020;14(1):23-27.

45. Araviiskaia E, Lopez Estebaranz JL, Pincelli C. Dermocosmetics: Beneficial adjuncts in the treatment of acne vulgaris. J Dermatolog Treat. 2021;32(1):3-10.